000			03105pam a2200385 i 4500
001			2022034219
003			DLC
005			20230824083853.0
008			220909s2023 nyu b 001 0 eng
010			_a 2022034219
020			_a9781982171964 _q(hardcover) : _c$28.00
040			_aDLC _beng _erda _cDLC
042			_apcc
043			_an-us---
050	0	0	_aRM172 _b.M39 2023
082	0	0	_a362.17/840973 _223
100	1		_aMcLaughlin, Kathleen _c(Journalist), _eauthor.
245	1	0	_aBlood money : _bthe story of life, death, and profit inside America's blood industry / _cKathleen McLaughlin.
250			_aFirst One Signal Publishers/Atria Books hardcover edition.
264		1	_aNew York : _bOne Signal Publishers/Atria, _c2023.
300			_a227 pages ; _c24 cm
336			_atext _btxt _2rdacontent
337			_aunmediated _bn _2rdamedia
338			_avolume _bnc _2rdacarrier
504			_aIncludes bibliographical references (pages 195-215) index.
510	4		_aKirkus Reviews, _cNovember 15, 2022
510	4		_aPublishers Weekly, _cDecember 12, 2022
510	4		_aBooklist, _cDecember 01, 2022
510	4		_aKirkus Starred Reviews
520			_a"Bad Blood meets Dreamland in this kaleidoscopic investigation into the shadowy and vampiric blood business and the dangerous limits of demand for the crucial resource that runs through our very veins. Every year, about twenty million Americans sell blood plasma for cash in a barely regulated market dominated by private industry and off-the-grid trafficking. These commercial efforts prey on an insatiable market for medical and scientific innovation fed from the veins of some of the country's most marginalized communities, such as undocumented immigrants and residents of poverty-stricken Flint, Michigan. We are often told that "blood donations" are used to save lives, but blood plasma, a component of whole blood, has become a precious commercial good. Blood plasma is collected and marketed by private industry, with the United States one of just five nations on the planet that have not yet banned the practice of pay-for-plasma giving. This precious resource is used for everything from expensive and unproven age-reversing treatments to costly and experimental cures for novel diseases like COVID-19. Based on a cross-country investigation into the plasma-giving capitals of the country, in-depth research into the blood industry, and her personal experience as a beneficiary of plasma-derived treatment for a rare condition, Kathleen McLaughlin's Blood Money reveals the underhanded machinations and unbalanced power structures of the blood industry. Taking us from China's blood black market to Silicon Valley's shadowy tech startups, this is an unforgettable inside look at an industry many of us had no idea even existed"-- _cProvided by publisher.
650		0	_aBlood banks _zUnited States.
650		0	_aBlood products _zUnited States.
650		0	_aPoverty _zUnited States.
776	0	8	_iOnline version: _aMcLaughlin, Kathleen. _tBlood money _dNew York : One Signal Publishers/Atria, 2023 _z9781982171988 _w(DLC) 2022034220
999			_c52399 _d52191